Filing status
- Accounts due
- 30 June 2027
- Last accounts
- 31 December 2025
- Conf. stmt due
- 2 October 2027
- Last conf. stmt
- 18 September 2026
Adaptimmune Therapeutics PLC
- Incorporated
- 3 December 2014 (11 years)
- Industry
- Research and experimental development on biotechnology (72110)
- Directors
- Garry Edward MenzelLawrence Michael Alleva
- Controlled by
- Details protected
- Accounts type
- Group
- Region
- South East
- Address
- The Innovation Centre 99 Park DriveMilton ParkAbingdonOX14 4RY
Charges
- Total
- 2
- Outstanding
- 0
- Part satisfied
- 0
- Satisfied
- 2
Officers 4 active
Officer details are public data from the Companies House register.
Hill, Christopher James
Secretary · Appointed 14 November 2025
Director · Appointed 14 November 2025
British
Born March 1980 (46)
Menzel, Garry Edward, Dr
Director · Appointed 1 June 2023
British
Born August 1964 (62)
Alleva, Lawrence Michael
Director · Appointed 5 March 2015
American
Born October 1949 (77)
Officer history (17 former)
14 November 2025
14 November 2025
14 November 2025
14 November 2025
Appointed Hill, Christopher James as Secretary
14 November 2025
Resigned Rawcliffe, Adrian George as Director
14 November 2025
Resigned Bertrand, William Charles as Secretary
14 November 2025
14 November 2025
Resigned Hege, Kristen, Dr as Director
14 November 2025
Resigned Hegde, Priti, Dr as Director
14 November 2025
1 October 2025
Appointed Bertrand, William Charles as Secretary
30 September 2025
Resigned Henry, Margaret as Secretary
1 November 2023
Appointed Hege, Kristen, Dr as Director
1 November 2023
1 June 2023
1 June 2023
1 June 2023
Appointed Hegde, Priti, Dr as Director
1 June 2023
Appointed Menzel, Garry Edward, Dr as Director
1 June 2023
Resigned Duncan, Barbara Gayle as Director
31 March 2023
Resigned Zaks, Tal Zvi, Dr as Director
29 May 2020
Resigned Kerr, Giles Francis Bertram as Director
1 September 2019
Appointed Rawcliffe, Adrian George as Director
5 July 2018
5 July 2018
31 December 2016
31 December 2016
14 November 2016
Appointed Zaks, Tal Zvi, Dr as Director
1 November 2016
Appointed Kerr, Giles Francis Bertram as Director
23 June 2016
Appointed Duncan, Barbara Gayle as Director
5 March 2015
Appointed Alleva, Lawrence Michael as Director
12 February 2015
12 February 2015
12 February 2015
12 February 2015
12 February 2015
12 February 2015
3 December 2014
3 December 2014
Appointed Henry, Margaret as Secretary
Ownership 1 active
People and entities with significant control, from the Companies House PSC register
Details protected
Exemptions
Holdings 2
Companies where Adaptimmune Therapeutics PLC is registered as a person with significant control
Owns 75–100% of shares
Active
Owns 75–100% of shares
Active
Filings
Recent filings only. See the full history on Companies House
| Date | Description | Made Up To | Pages | |
|---|---|---|---|---|
| 20 July 2026 | Resolutions | |||
| 31 May 2026 | Group of companies' accounts | 31 December 2025 | ||
| 25 March 2026 | Registered office address changed | |||
| 25 March 2026 | Registered office address changed | |||
| 17 November 2025 | Termination of appointment of a secretary |
Some other companies at this address
Other companies in this industry
Sandwich
Newcastle Upon Tyne
Edinburgh
Need accounts figures, ownership or websites for thousands of companies? Bulk data & API →